STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

CDLX CARDLYTICS INCORPORATED StockScouter® Report

5

StockScouter® Score

CARDLYTICS INCORPORATED, a micro cap value company in the technology sector, is expected to perform in line with the market over the next six months with higher than average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • The most recent quarterly earnings report higher than analysts’ consensus forecast. Positive
  • One or more less experienced analysts has modestly increased quarterly earnings estimates for CDLX. Positive/Neutral

 

Concerns

  • Two or more executives, board directors or major shareholders – including one high-level executive -- sold a large number of shares recently. Very negative
  • Moving average analysis for CDLX suggests weak price movement over the medium term. Negative

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that micro cap stocks will be in favor, value stocks will be neutral, and technology stocks will be in favor.

Expected Risk/Return

Progress: 100% done.
Progress: 60% done.
Low
High

Core Model Grades

B
F
C
D

Previous Ratings

5
5
2